A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis

Abstract

described to function in a similar manner to the YODA project, that is, requiring formal request and access to data via a secure platform. A potential benefit of these platforms, which have multiple data partners, is that they may allow combined analyses of data from multiple different trials.In summary, the YODA platform is a free and extensive source of trial data (both published and unpublished), which can be used to carry out meta-analysis or to analyze individual level data. The range of trial data available has potentially wide applications for clinical psychopharmacology research, for example, analyses of response to treatment, adverse effects, physiologic changes, and pharmacokinetics. Researchers who are interested in using YODA need to establish whether the specific data of interest are available and that the planned analysis can be conducted using YODA approved programs.